Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 4:05 AM
Ignite Modification Date:
2025-12-26 @ 3:00 AM
NCT ID:
NCT01723202
Group ID:
EG002
Title:
Crossover to Dabrafenib + Trametinib
Description:
Patients receive dabrafenib orally twice a day and trametinib orally once a day on days 1-28.
dabrafenib: 150 mg orally twice daily given orally
trametinib: 150 mg orally twice daily and GSK1120212 (MEKi) 2 mg orally once daily given orally
Deaths Number Affected:
2
Deaths Number At Risk:
None
Serious Number Affected:
0
Serious Number At Risk:
14
Other Number Affected:
14
Other Number At Risk:
14
Study:
NCT01723202
Results Section:
NCT01723202
Adverse Events Module:
NCT01723202